根治性前列腺切除术前多参数MRI识别前列腺癌筛状结构与导管内生长方式
回顾性纳入124例根治性前列腺切除术前接受mpMRI的患者,病理检出筛状结构/导管内癌89/124例(71%),mpMRI对含筛状结构/导管内癌肿瘤的灵敏度为90.5%(95%CI 82.8-95.6%)。在GG2肿瘤中,伴筛状结构/导管内癌者生化复发11/31(35.5%),不伴者2/21(9.5%)(P=0.034)。
要点
- mpMRI对含筛状结构/导管内癌的前列腺癌灵敏度为90.5%(95%CI 82.8-95.6%)。
- 124例中病理检出筛状结构/导管内癌89例(71%)。
- GG2肿瘤中伴筛状结构/导管内癌者生化复发率35.5%,不伴者9.5%(P=0.034)。
核心结论
- mpMRI对病理原发性前列腺癌(包括多数伴筛状结构/导管内癌病例)具有良好灵敏度,但可靠预测GG2肿瘤伴筛状结构/导管内癌以实现个体化风险分层仍具挑战。
研究设计与样本
- 回顾性研究,纳入本中心根治性前列腺切除术前接受mpMRI的124例男性,复习术前mpMRI、前列腺切除病理及临床随访资料。
主要发现
- 根治性前列腺切除标本病理检出筛状结构/导管内癌89/124例(71%)。
- mpMRI识别含任何筛状结构/导管内癌肿瘤86/95例,灵敏度90.5%(95%CI 82.8-95.6%)。
- 最高PI-RADS分类与最高病理分级一致者106/124例(85.5%)。
- GG2病变中,伴筛状结构/导管内癌者生化复发11/31(35.5%),不伴者2/21(9.5%)(P=0.034)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the diagnostic value of multiparametric prostate magnetic resonance imaging (mpMRI) prior to radical prostatectomy with curative intent for the detection of cribriform architecture (CA) and intraductal prostate cancer (IDC), which have recently been demonstrated to be adverse pathological features. PATIENTS AND METHODS: The study included 124 men who underwent mpMRI prior to radical prostatectomy at our centre. Preoperative mpMRI, prostatectomy histology and clinical follow-up details were reviewed retrospectively. The diagnostic value of mpMRI was evaluated on the basis of the detection rate. Secondly, the prognostic significance of CA/IDC among grade group (GG)2 cancers with regard to biochemical recurrence (BCR)-free survival was assessed using Kaplan-Meier analysis, with the log rank test and Fisher's exact test. RESULTS: Pathological examination of radical prostatectomy specimens identified CA/IDC in 89 of 124 cases (71%) and mpMRI identified 86/95 of tumours including any CA/IDC with a sensitivity of 90.5% (95% confidence interval 82.8-95.6%). When localization of the lesions was compared, there was an association between the highest Prostate Imaging-Reporting and Data System classification and the highest pathological grade in 106 of the 124 cases (85.5%). In patients with GG2 lesions, BCR occurred in 11 of 31 (35.5%) with CA/IDC and two of 21 (9.5%) without CA/IDC (P = 0.034). CONCLUSION: Multiparametric MRI has good sensitivity for detection of pathological primary prostate cancer, including most cases with CA/IDC; however, reliable prediction of GG2 tumours with CA/IDC for individual risk stratification remains challenging.
引用
- Tonttila PP, Ahtikoski A, Kuisma M, et al. Multiparametric MRI prior to radical prostatectomy identifies intraductal and cribriform growth patterns in prostate cancer. BJU Int. 2019. PMID: 31102571. doi:10.1111/bju.14812
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。